by John Conrad | Jun 21, 2024 | iBIO News
Illinois Biotechnology Innovation Organization Announces Rheoxtech as Winner of Inaugural Timothy P. Walbert Entrepreneurship Impact Award CHICAGO, IL (June 21, 2024) – The Illinois Biotechnology Innovation Organization (iBIO) is pleased to announce that Rheoxtech has...
by John Conrad | Jun 6, 2024 | NewsBrief
The biopharma sector has undergone significant changes in venture funding and investment trends during the first quarter of 2024, according to a recent PitchBook report. Despite a decrease in deal count, the sector saw an increase in venture funding, with $7.4 billion...
by John Conrad | May 31, 2024 | iBIO News
iBIO unveiled the six finalists vying for the inaugural Timothy P. Walbert Entrepreneurship Impact Award, a prestigious $50,000 prize recognizing outstanding Illinois entrepreneurs in the life sciences industry. The finalists for this first-ever competition are:...
by John Conrad | May 29, 2024 | NewsBrief
Early drug development requires critical decisions under severe time and cost pressure. Data comes from multiple parallel activities and identifying possible key risks can be a challenge for companies with limited resources, a position many small biotechs find...
by John Conrad | Mar 13, 2020 | Policy News
From BIO: The Securities and Exchange Commission (SEC) has adopted regulatory changes to provide small public companies with a temporary exemption from Sarbanes-Oxley 404(b) compliance. 404(b) requires public companies to report on the internal controls they have in...
